X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (38202) 38202
Book Review (8748) 8748
Publication (2354) 2354
Conference Proceeding (91) 91
Book Chapter (81) 81
Magazine Article (35) 35
Dissertation (11) 11
Data Set (5) 5
Book / eBook (2) 2
Trade Publication Article (2) 2
Presentation (1) 1
Report (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (33268) 33268
humans (32438) 32438
multicenter (19374) 19374
female (17950) 17950
male (16544) 16544
middle aged (14014) 14014
adult (11409) 11409
aged (11351) 11351
treatment outcome (9570) 9570
multicenter studies as topic (9503) 9503
oncology (6925) 6925
randomized controlled trials as topic (5115) 5115
clinical trials (4926) 4926
double-blind (4868) 4868
surgery (4631) 4631
abridged index medicus (4617) 4617
care and treatment (4372) 4372
prospective studies (4179) 4179
aged, 80 and over (4047) 4047
clinical trials as topic (3757) 3757
cancer (3726) 3726
therapy (3620) 3620
adolescent (3562) 3562
analysis (3531) 3531
chemotherapy (3510) 3510
efficacy (3359) 3359
double-blind method (3323) 3323
pharmacology & pharmacy (3277) 3277
medicine & public health (3241) 3241
risk factors (3200) 3200
trial (3195) 3195
time factors (3189) 3189
follow-up studies (3099) 3099
research (3090) 3090
retrospective studies (2792) 2792
clinical neurology (2651) 2651
antineoplastic combined chemotherapy protocols - therapeutic use (2594) 2594
prognosis (2572) 2572
health aspects (2458) 2458
medicine, general & internal (2458) 2458
mortality (2427) 2427
drug therapy (2423) 2423
cardiac & cardiovascular systems (2292) 2292
patients (2288) 2288
safety (2278) 2278
management (2218) 2218
child (2130) 2130
survival (2088) 2088
young adult (1991) 1991
hematology (1934) 1934
medical research (1914) 1914
gastroenterology & hepatology (1895) 1895
multicenter trial (1820) 1820
quality of life (1820) 1820
medicine, research & experimental (1738) 1738
open-label (1655) 1655
drug administration schedule (1635) 1635
survival analysis (1574) 1574
studies (1564) 1564
diagnosis (1534) 1534
drug therapy, combination (1522) 1522
animals (1517) 1517
usage (1505) 1505
severity of illness index (1484) 1484
dose-response relationship, drug (1410) 1410
medicine (1395) 1395
outcomes (1391) 1391
prevention (1378) 1378
combined modality therapy (1370) 1370
survival rate (1369) 1369
risk (1356) 1356
placebo-controlled trial (1353) 1353
follow-up (1352) 1352
antineoplastic agents - therapeutic use (1340) 1340
research design (1337) 1337
clinical-trial (1326) 1326
disease-free survival (1301) 1301
neoplasm staging (1299) 1299
united states (1296) 1296
disease (1295) 1295
urology & nephrology (1282) 1282
metaanalysis (1276) 1276
psychiatry (1275) 1275
medicine, experimental (1271) 1271
recurrence (1265) 1265
internal medicine (1196) 1196
child, preschool (1180) 1180
metastasis (1167) 1167
quality-of-life (1158) 1158
neurosciences (1148) 1148
patient outcomes (1147) 1147
children (1145) 1145
article (1138) 1138
clinical-trials (1137) 1137
randomized-trial (1136) 1136
pediatrics (1134) 1134
antineoplastic combined chemotherapy protocols - adverse effects (1093) 1093
cohort studies (1082) 1082
randomized controlled-trial (1080) 1080
complications (1079) 1079
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (36266) 36266
German (560) 560
French (528) 528
Japanese (331) 331
Spanish (285) 285
Italian (113) 113
Russian (58) 58
Chinese (46) 46
Polish (19) 19
Portuguese (19) 19
Danish (18) 18
Hungarian (14) 14
Dutch (12) 12
Korean (6) 6
Norwegian (6) 6
Swedish (6) 6
Hebrew (3) 3
Lithuanian (3) 3
Czech (2) 2
Catalan (1) 1
Croatian (1) 1
Finnish (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 08/2016, Volume 316, Issue 5, pp. 509 - 518
Journal Article
Current opinion in neurology, ISSN 1350-7540, 06/2019, Volume 32, Issue 3, pp. 358 - 364
Recent years have seen the approval of more than 15 disease-modifying drugs for multiple sclerosis (MS), mainly for its relapsing-remitting form (RRMS). The... 
BRAIN ATROPHY | PLACEBO | MULTICENTER | multiple sclerosis | PROGRESSIVE MS | MAGNETIZATION-TRANSFER | clinical trial design | NEUROSCIENCES | CLINICAL NEUROLOGY | OUTCOME MEASURES | RECOMMENDATIONS | DOUBLE-BLIND | DISABILITY | INTERFERON BETA-1B | Multiple sclerosis | Analysis | Clinical trials | Dosage and administration | Research | Drug therapy | Neuroprotective agents
Journal Article
Ophthalmology, ISSN 0161-6420, 2016, Volume 123, Issue 10, pp. 2248 - 2254
Journal Article
JAMA, ISSN 0098-7484, 02/2014, Volume 311, Issue 7, pp. 682 - 691
Journal Article
ARTHRITIS & RHEUMATOLOGY, ISSN 2326-5191, 09/2018, Volume 70, Issue 9, pp. 1364 - 1365
Journal Article
JAMA, ISSN 0098-7484, 11/2013, Volume 310, Issue 20, pp. 2174 - 2183
Journal Article
JAMA, ISSN 0098-7484, 10/2017, Volume 318, Issue 16, pp. 1569 - 1580
Journal Article
JAMA, ISSN 0098-7484, 02/2015, Volume 313, Issue 5, pp. 471 - 482
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 2/2008, Volume 100, Issue 4, pp. 261 - 269
Journal Article
JAMA, ISSN 0098-7484, 06/2017, Volume 317, Issue 24, pp. 2493 - 2501
Journal Article